Drug Trial News

RSS
Anemia treatment for patients with kidney disease can differ by dialysis facility type

Anemia treatment for patients with kidney disease can differ by dialysis facility type

Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells

Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells

Clioquinol shows promise in fighting cancer

Clioquinol shows promise in fighting cancer

Advanced age associated with poorer bladder cancer-specific survival in radical cystectomy patients

Advanced age associated with poorer bladder cancer-specific survival in radical cystectomy patients

Brain tumor vaccine shows promise

Brain tumor vaccine shows promise

New hope for spinal cord injury sufferers

New hope for spinal cord injury sufferers

Common misconception that diabetes is 'in the genes' for Indigenous people dispelled

Common misconception that diabetes is 'in the genes' for Indigenous people dispelled

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Anti-anemia drug darbepoetin alfa no better than placebo for cancer patients

Selenium as therapy for prostate cancer

Selenium as therapy for prostate cancer

A strong marital relationship helps deal with tempermental babies

A strong marital relationship helps deal with tempermental babies

Embryonic stem cells provide new tool for studying disease and identifying ALS drugs

Embryonic stem cells provide new tool for studying disease and identifying ALS drugs

Side-effects of treatment for localized prostate cancer

Side-effects of treatment for localized prostate cancer

Study identifies high-risk patient populations for MRSA carriage

Study identifies high-risk patient populations for MRSA carriage

A candidate neural circuit for stress-induced analgesia

A candidate neural circuit for stress-induced analgesia

Study identifies trends in cerebral aneurysm treatment

Study identifies trends in cerebral aneurysm treatment

Predicting cancer risk in the long term

Predicting cancer risk in the long term

Progen Pharmaceuticals announces positive results in PI-88 trial

Progen Pharmaceuticals announces positive results in PI-88 trial

Natalizumab (Tysabri) reduces vision loss in MS patients

Natalizumab (Tysabri) reduces vision loss in MS patients

Study dispels myth that certain minority groups are genetically prone to diabetes

Study dispels myth that certain minority groups are genetically prone to diabetes

Most-at-risk nursing home residents to be tested for superbugs

Most-at-risk nursing home residents to be tested for superbugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.